GlobeStar Therapeutics Corporation
GSTC
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 84.58% | -16.51% | 1.27% | -13.72% | -711.20% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -54.88% | 12.90% | -43.01% | -9.43% | -4.65% |
| Total Other Non-Cash Items | -101.19% | 32.58% | 40.45% | 691.97% | 4,358.57% |
| Change in Net Operating Assets | 62.43% | 82.32% | -8.94% | -34.86% | 50.52% |
| Cash from Operations | 49.25% | 76.91% | -9.46% | -88.34% | 16.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 41.11% | 1,850.00% | 4,960.00% | 714.00% | -24.69% |
| Total Debt Repaid | 9.09% | -- | -- | -- | 66.67% |
| Issuance of Common Stock | -100.00% | 118.75% | 250.00% | 540.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.00% | -73.16% | 5.68% | 61.56% | -15.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00% | -- | -- | -100.00% | 66.67% |